Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role? ; volume:12 ; number:04 ; year:2021 ; pages:e1-e1
Journal of neurosciences in rural practice ; 12, Heft 04 (2021), e1-e1
- Contributor
-
Vandana, Valiyaparambath Purushothaman
Darshini, Jeevendra Kumar
Vikram, Venkappayah Holla
Nitish, Kamble
Pal, Pramod Kumar
Ravi, Yadav
- DOI
-
10.1055/s-0042-1743280
- URN
-
urn:nbn:de:101:1-2022041410422414045154
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vandana, Valiyaparambath Purushothaman
- Darshini, Jeevendra Kumar
- Vikram, Venkappayah Holla
- Nitish, Kamble
- Pal, Pramod Kumar
- Ravi, Yadav
Other Objects (12)
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Erratum to: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Erratum to: Gastrointestinal Dysfunction in a Parkinson’s Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric Plexus
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Erratum to: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Erratum to: Gastrointestinal Dysfunction in a Parkinson’s Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric Plexus
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Erratum to: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Erratum to: Gastrointestinal Dysfunction in a Parkinson’s Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric Plexus
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment